Seroepidemiology of toxoplasma gondii infection in patients with vision and hearing impairments, cancer, HIV, or undergoing hemodialysis in durango, Mexico

Journal of Parasitology

Volumn 96, Issue 3, 2010, Pages 505-508

  Alvarado Esquivel, C ^a   Liesenfeld, O ^a,b,c,d   Torres Castorena, A ^a,d   Estrada Martinez S ^a,e   Urbina Alvarez J D ^a,d   Ramos De La Rocha, M ^a,d   Marquez Conde J A ^a   Dubey, J P ^a  

^a UNIVERSIDAD JUÁREZ DEL ESTADO DE DURANGO   (Mexico)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Roche Diagnostics   (United States)

^d INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^e Jurez University of Durango State   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ANTIBODY; CANCER; DISEASE CONTROL; DISEASE PREVALENCE; EPIDEMIOLOGY; HEALTH POLICY; HEALTH RISK; HUMAN IMMUNODEFICIENCY VIRUS; MULTIVARIATE ANALYSIS; PARASITIC DISEASE; PROTOZOAN; PUBLIC HEALTH; SENSORY SYSTEM DISORDER; SERUM; SYMPTOM;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ASSESSMENT; CONTROLLED STUDY; EATING; FEMALE; FOOD INTAKE; HEARING IMPAIRMENT; HEMODIALYSIS; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; MALE; MEXICO; MULTIVARIATE ANALYSIS; RISK ASSESSMENT; SCHOOL CHILD; SEROEPIDEMIOLOGY; SEROPREVALENCE; STATISTICAL SIGNIFICANCE; TOXOPLASMA GONDII; TOXOPLASMOSIS; VISUAL IMPAIRMENT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIBODIES, PROTOZOAN; CATS; CHILD; CHILD, PRESCHOOL; FEMALE; HEARING DISORDERS; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; KIDNEY FAILURE; LOGISTIC MODELS; MALE; MEXICO; MIDDLE AGED; NEOPLASMS; RENAL DIALYSIS; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; TOXOPLASMA; TOXOPLASMOSIS; VISION DISORDERS; YOUNG ADULT;

DURANGO; MEXICO [NORTH AMERICA];

ANIMALIA; TOXOPLASMA GONDII;

EID: 77953830893     PISSN: 00223395     EISSN: 19372345     Source Type: Journal    
DOI: 10.1645/GE-2378.1     Document Type: Article

References (15)

1. ALVARADO-ESQUIVEL, C., A. SIFUENTES-Á LVAREZ, S.G.NARRO-DUARTE, S. ESTRADA-MARTÍNEZ, J. H. DÍAZ-GARCÍA, O. LIESENFELD, S. A. MARTÍNEZ-GARCÍA, AND A. CANALES-MOLINA. 2006. Seroepidemiology of Toxoplasma gondii infection in pregnant women in a public hospital in northern Mexico. BMC Infectious Diseases 6: 113.
2. -, M. F. MERCADO-SUÁ REZ, A. RODRÍGUEZ-BRIONES, L. FALLADTORRES, J. O. AYALA-AYALA, L. J. NEVÁ REZ-PIEDRA, E. DURANMORALES, S. ESTRADA-MARTÍNEZ, O. LIESENFELD, J. A. MÁ RQUEZCONDE, AND S. A. MARTÍNEZ-GARCÍA. 2007. Seroepidemiology of infection with Toxoplasma gondii in healthy blood donors of Durango, Mexico. BMC Infectious Diseases 7: 75.
3. DUBEY, J. P. 2009. Toxoplasmosis of animals and humans, 2nd ed. CRC Press, Boca Raton, Florida, 313 p.
4. FLEGR, J., J. HAVLÍCEK, P. KODYM, M. MALÝ, AND Z. SMAHEL. 2002. Increased risk of traffic accidents in subjects with latent toxoplasmosis: A retrospective case-control study. BMC Infectious Diseases 2: 11.
5. KOCAZEYBEK, B., Y. A. ONER, R. TURKSOY, C. BABUR, H. CAKAN, N. SAHIP, A. UNAL, A. OZASLAN, S.KILIC, S. SARIBAS ET AL. 2009. Higher prevalence of toxoplasmosis in victims of traffic accidents suggest increased risk of traffic accident in Toxoplasma-infected inhabitants of Istanbul and its suburbs. Forensic Science International 187: 103-108.
6. MONTOYA, J. G., AND O. LIESENFELD. 2004. Toxoplasmosis. Lancet 363: 1965-1976.
7. -, AND J. S. REMINGTON. 2008. Management of Toxoplasma gondii infection during pregnancy. Clinical Infectious Diseases 47: 554-566.
8. OCAK, S., N. DURAN, A. F. ESKIOCAK, AND H. AYTAC. 2005. Anti- Toxoplasma gondii antibodies in hemodialysis patients receiving longterm hemodialysis therapy in Turkey. Saudi Medical Journal 26: 1378-1382.
9. RADON, K., D. WINDSTETTER, J. ECKART, H. DRESSEL, L. LEITRITZ, J. REICHERT, M. SCHMID, G. PRAML, M. SCHOSSER, E. VON MUTIUS, AND D. NOWAK. 2004. Farming exposure in childhood, exposure to markers of infections and the development of atopy in rural subjects. Clinical and Experimental Allergy 34: 1178-1183.
10. RAI, S. K., M. P. UPADHYAY, AND H. G. SHRESTHA. 2003. Toxoplasma infection in selected patients in Kathmandu, Nepal. Nepal Medical College Journal 5: 89-91.
11. SHIN, D. W., D. Y. CHA, Q. J. HUA, G. H. CHA, AND Y. H. LEE. 2009. Seroprevalence of Toxoplasma gondii infection and characteristics of seropositive patients in general hospitals in Daejeon, Korea. Korean Journal of Parasitology 47: 125-130.
12. VELASCO-CASTREJÓ N, O., B. SALVATIERRA-IZABA, J. L. VALDESPINO, A. M. SEDANO-LARA, S.GALINDO-VIRGEN, C. MAGOS, A. LLAUSAS, R. TAPIACONVER, G.GUTIERREZ, AND J. SEPULVEDA. 1992. Seroepidemiology of toxoplasmosis in México. Salud Pú blica de México 34: 222-229.
13. YAZAR, S., F. DEMIRTAŞ, S. YALÇIN, O. YAMAN O, B. TOKGÖ Z, C. UTAŞ, AND I. SAHIN. 2003. Anti-Toxoplasma gondii antibodies in haemodialysis patients with chronic renal failure. Yonsei Medical Journal 44: 288-292.
14. YERELI, K., I. C. BALCIOǦ LU, AND A. OZBILGIN. 2006. Is Toxoplasma gondii a potential risk for traffic accidents in Turkey? Forensic Science International 163: 34-37.
15. YUAN, Z., S. GAO, Q. LIU, X. XIA, X. LIU, B. LIU, AND R. HU. 2007. Toxoplasma gondii antibodies in cancer patients. Cancer Letters 254: 71-74.